Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04628832 · ClinicalTrials.gov registry record · NA
Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 12,000
- Enrollment target
NCT04628832 is a NA study that has completed, run by Columbia University. The registered enrollment target is 12,000 participants.
The verdict
NCT04628832, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,000 participants
- Enrollment target
Study Summary
Despite an enormous policy response, opioid prescribing remains well above historical levels and harms from opioids continue to mount. Nearly all states have Prescription Monitoring Programs (PMPs) to facilitate safer prescribing of opioids and other drugs, but research suggests these systems only deliver benefits when health care professionals are required to use them. Even with PMP mandates in place, providers may be unaware of the dangers of co-prescribing opioids with benzodiazepines or gabapentinoids, which include increased risk of overdose and death. Working with the Minnesota state government, the investigators will mail letters to guideline-discordant opioid prescribers that either highlight an upcoming legally mandated requirement to check the PMP before prescribing an opioid, inform and educate providers about patients filling concurrent prescriptions and the dangers of such co-prescribing, or both. Study participants will be randomized to receive no intervention or one of the three treatment letters. Using administrative data, the investigators will track effects of the letters on not only prescribing but also PMP usage and queries. Findings form the multiplicity of treatment messages and outcomes will shed light on the mechanisms driving overprescribing. Results will inform future work by state and local policymakers to make opioid prescribing safer.
Interventions
- BEHAVIORAL PMP Use Mandate Letter
- BEHAVIORAL Prescribing Information Letter
- BEHAVIORAL Prescribing Information + PMP Use Mandate Letter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,000 participants |
| Start Date | 2021-04-15 |
| Est. Completion | 2021-07-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04628832
The ClinicalTrials.gov registry entry for NCT04628832 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which PMP Use Mandate Letter is the first listed.
NCT04628832 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04628832 about?
NCT04628832 is a clinical study titled "Nudging Providers to Curtail Dangerous Opioid Prescribing: A Trial to Investigate Mechanisms". Despite an enormous policy response, opioid prescribing remains well above historical levels and harms from opioids continue to mount. Nearly all states have Prescription Monitoring Programs (PMPs) to facilitate safer prescribing of opioids and other drugs, but research suggests these systems only d...
What is the current status of trial NCT04628832?
This trial is currently completed. It is a NA study. The enrollment target is 12,000 participants. The study started on 2021-04-15. Estimated completion is 2021-07-12.
What interventions are being tested in trial NCT04628832?
The interventions under investigation include: PMP Use Mandate Letter (BEHAVIORAL), Prescribing Information Letter (BEHAVIORAL), Prescribing Information + PMP Use Mandate Letter (BEHAVIORAL).
Who is sponsoring clinical trial NCT04628832?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.